The new toolkit, developed by Penn Medicine and Children’s Hospital of Philadelphia, allows researchers to test potential cancer targets directly in patient leukemia cells.
A clinical trial led by scientists from the Abramson Cancer Center and the Perelman School of Medicine offers proof-of-concept for a treatment approach to prevent breast cancer recurrence.